Tailored Interventions to Improve Hypertension Management After Stroke or Transient Ischemic Attack (TIA)

Blood Pressure Clinical Trial

— TIMSII  

Official title:

Tailored Interventions to Improve Hypertension Management After Stroke or TIA

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01038375
• Other study ID #: OSN0912-000106
• Status: Completed
• Phase: N/A
• First received: December 22, 2009
• Last updated: April 30, 2012
• Start date: March 2010
• Est. completion date: October 2011

Study information

• Verified date: April 2012
• Source: McMaster University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of interventions to improve adherence to medication and healthier lifestyle choices on blood pressure over a 6 month period in a group of people at high risk for recurrent stroke events. The participants have already had a stroke or TIA, and have uncontrolled blood pressure, as well as problems with memory and problem-solving, or miss taking medications, or who do not believe in the effectiveness of their medications. Interventions focus on motivational interviewing, adherence counseling with memory cuing, and self-monitoring of blood pressure.

Description:

• randomized, controlled trial at 4 sites

• measurement of blood pressure, missed pills, self-efficacy rating at baseline and 6 months

• contacting family pharmacists to evaluate prescription renewal patterns at baseline and 6 months

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: October 2011
• Est. primary completion date: October 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• diagnosis of stroke or TIA

• hypertension

• Montreal Cognitive Assessment score less than 26

• self report of missed pills

• self-efficacy rating less than 100%

Exclusion Criteria:

• inability to give informed consent

• 18 years of age or younger

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Blood Pressure
• Hypertension
• Ischemic Attack, Transient

Intervention

Behavioral:
• lifestyle counseling, home blood pressure monitoring
monthly telephone counseling over 6 months for intervention group no health provider initiated contact for control group

Locations

Country	Name	City	State
Canada	Royal Victoria Hospital	Barrie	Ontario
Canada	Hamilton General Hospital, 237 Barton St East	Hamilton	Ontario
Canada	Lakeridge Health Centre	Oshawa	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Hamilton Health Sciences Corporation	Heart and Stroke Foundation of Ontario

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	blood pressure		6 months from baseline testing	No
Secondary	self-efficacy rating		6 months from baseline	No